JAJürgen Arund

Jürgen Arund

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jürgen Arund has a total of 490 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Online Uric Acid Concentration Estimation in Blood from Spent Dialysate Measurements Using an Optical Sensor

    by Joosep Paats, Jürgen Arund, Kristjan Pilt, Annika Adoberg, Liisi Leis, Merike Luman, Jana Holmar, Risto Tanner, Ivo Fridolin

  • Open Access

    Time-averaged concentration estimation of uraemic toxins with different removal kinetics: a novel approach based on intradialytic spent dialysate measurements

    by Joosep Paats, Annika Adoberg, Jürgen Arund, Annemieke Dhondt, Anders Fernström, Ivo Fridolin, Griet Glorieux, Emilio Gonzalez-Parra, Jana Holmar, Liisi Leis, et al.

    Kt/Vurea is the most used marker to estimate dialysis adequacy; however, it does not reflect the removal of many other uremic toxins, and a new approach is needed. We have assessed the feasibility of estimating intradialytic serum time-averaged concentration (TAC) of various uremic toxins from their spent dialysate concentrations that can be estimated non-invasively online with optical methods. Serum and spent dialysate levels and total removed solute (TRS) of urea, uric acid (UA), indoxyl sulfate (IS) and β2-microglobulin (β2M) were evaluated with laboratory methods during 312 hemodialysis sessions in 78 patients with 4 different dialysis treatment settings. TAC was calculated from serum concentrations and evaluated from TRS and logarithmic mean concentrations of spent dialysate (Mln D). Mean intradialytic serum TAC values of urea, UA, β2M and IS were 10.4±3.8 mmol/L, 191.6±48.1 µmol/L, 13.3±4.3 mg/L and 82.9±43.3 µmol/L, respectively. These serum TAC values were similar and highly correlated to those estimated from TRS: 10.5±3.6 mmol/L (R2 = 0.92), 191.5±42.8 µmol/L (R2 = 0.79), 13.0±3.2 mg/L (R2 = 0.59), and 82.7±40.0 µmol/L (R2 = 0.85) and from Mln D 10.7±3.7 mmol/L (R2 = 0.92), 191.6±43.8 µmol/L (R2 = 0.80), 12.9±3.2 mg/L (R2 = 0.63), and 82.2±38.6 µmol/L (R2 = 0.84), respectively. Intradialytic serum TAC of different uremic toxins can be estimated non-invasively from their concentration in spent dialysate. This sets the stage for TAC estimation from online optical monitoring of spent dialysate concentrations of diverse solutes and for further optimization of estimation models for each uremic toxin.


  • Open Access

    Treatment with Paracetamol Can Interfere with the Intradialytic Optical Estimation in Spent Dialysate of Uric Acid but Not of Indoxyl Sulfate

    by Annika Adoberg, Joosep Paats, Jürgen Arund, Annemieke Dhondt, Ivo Fridolin, Griet Glorieux, Jana Holmar, Kai Lauri, Liisi Leis, Merike Luman, et al.

    Optical online methods are used to monitor the haemodialysis treatment efficiency of end stage kidney disease (ESKD) patients. The aim of this study was to analyse the effect of the administration of UV-absorbing drugs, such as paracetamol (Par), on the accuracy of optical monitoring the removal of uremic toxins uric acid (UA) and indoxyl sulfate (IS) during standard haemodialysis (HD) and haemodiafiltration (HDF) treatments. Nine patients received Par in daily dosages 1–4 g for 30 sessions. For 137 sessions, in 36 patients the total daily dosage of UV-absorbing drugs was less than 500 mg, and for 6 sessions 3 patients received additional UV-absorbing drugs. Par administration slightly affected the accuracy of optically assessed removal of UA expressed as bias between optically and laboratory-assessed reduction ratios (RR) during HD but not HDF employing UV absorbance of spent dialysate (p < 0.05) at 295 nm wavelength with the strongest correlation between the concentration of UA and absorbance. Corresponding removal of IS based on fluorescence at Ex280/Em400 nm during HD and HDF was not affected. Administration of UV-absorbing drugs may in some settings influence the accuracy of optical assessments in spent dialysate of the removal of uremic solutes during haemodialysis treatment of ESKD patients.


  • Open Access

    Optical Method and Biochemical Source for the Assessment of the Middle-Molecule Uremic Toxin β2-Microglobulin in Spent Dialysate

    by Joosep Paats, Annika Adoberg, Jürgen Arund, Ivo Fridolin, Kai Lauri, Liisi Leis, Merike Luman, Risto Tanner

    Optical monitoring of spent dialysate has been used to estimate the removal of water-soluble low molecular weight as well as protein-bound uremic toxins from the blood of end stage kidney disease (ESKD) patients. The aim of this work was to develop an optical method to estimate the removal of β2-microglobulin (β2M), a marker of middle molecule (MM) uremic toxins, during hemodialysis (HD) treatment. Ultraviolet (UV) and fluorescence spectra of dialysate samples were recorded from 88 dialysis sessions of 22 ESKD patients, receiving four different settings of dialysis treatments. Stepwise regression was used to obtain the best model for the assessment of β2M concentration in the spent dialysate. The correlation coefficient 0.958 and an accuracy of 0.000 ± 0.304 mg/L was achieved between laboratory and optically estimated β2M concentrations in spent dialysate for the entire cohort. Optically and laboratory estimated reduction ratio (RR) and total removed solute (TRS) of β2M were not statistically different (p > 0.35). Dialytic elimination of MM uremic toxin β2M can be followed optically during dialysis treatment of ESKD patients. The main contributors to the optical signal of the MM fraction in the spent dialysate were provisionally identified as tryptophan (Trp) in small peptides and proteins, and advanced glycation end-products.


  • Open Access

    Serum Levels and Removal by Haemodialysis and Haemodiafiltration of Tryptophan-Derived Uremic Toxins in ESKD Patients

    by Joosep Paats, Annika Adoberg, Jürgen Arund, Annemieke Dhondt, Anders Fernström, Ivo Fridolin, Griet Glorieux, Liisi Leis, Merike Luman, Emilio Gonzalez-Parra, et al.

    Tryptophan is an essential dietary amino acid that originates uremic toxins that contribute to end-stage kidney disease (ESKD) patient outcomes. We evaluated serum levels and removal during haemodialysis and haemodiafiltration of tryptophan and tryptophan-derived uremic toxins, indoxyl sulfate (IS) and indole acetic acid (IAA), in ESKD patients in different dialysis treatment settings. This prospective multicentre study in four European dialysis centres enrolled 78 patients with ESKD. Blood and spent dialysate samples obtained during dialysis were analysed with high-performance liquid chromatography to assess uremic solutes, their reduction ratio (RR) and total removed solute (TRS). Mean free serum tryptophan and IS concentrations increased, and concentration of IAA decreased over pre-dialysis levels (67%, 49%, −0.8%, respectively) during the first hour of dialysis. While mean serum total urea, IS and IAA concentrations decreased during dialysis (−72%, −39%, −43%, respectively), serum tryptophan levels increased, resulting in negative RR (−8%) towards the end of the dialysis session (p < 0.001), despite remarkable Trp losses in dialysate. RR and TRS values based on serum (total, free) and dialysate solute concentrations were lower for conventional low-flux dialysis (p < 0.001). High-efficiency haemodiafiltration resulted in 80% higher Trp losses than conventional low-flux dialysis, despite similar neutral Trp RR values. In conclusion, serum Trp concentrations and RR behave differently from uremic solutes IS, IAA and urea and Trp RR did not reflect dialysis Trp losses. Conventional low-flux dialysis may not adequately clear Trp-related uremic toxins while high efficiency haemodiafiltration increased Trp losses.


  • Optical measurement of 4-pyridoxic acid in the spent dialysate: Algorithm Development

    by Sigrid Kalle, Risto Tanner, Jurgen Arund, Ruth Tomson, Ivo Fridolin

    The aim of this study was to develop an algorithm suitable for the estimation of 4-pyridoxic acid (4PA) concentration removed during dialysis through fluorescence measurements in spent dialysate. 4PA is the major urinary catabolite of vitamin B-6 (B6), that is regularly injected to dialysis patients. 4PA could be used to estimate B6 nutritional status of the patients. For the study 10 hemodialysis patients during 40 dialysis sessions were studied. Full fluorescence spectra of spent dialysates were recorded with the spectrofluorophotometer RF-5301 by Shimadzu (Kyoto, Japan) and 4-pyridoxic acid concentrations were measured with HPLC system. Two single wavelength models were developed were correlation coefficients for Ex/Em 320/430 nm were 0.931 and 0.853 and for Ex/Em 310/460 nm were 0.944 and 0.931 for calibration and validation set, respectively. In summary, 4PA concentration can be estimated through fluorescence measurements from spent dialysate.

  • Open Access

    Is Fluorescence Valid to Monitor Removal of Protein Bound Uremic Solutes in Dialysis?

    by Jürgen Arund, Merike Luman, Fredrik Uhlin, Risto Tanner, Ivo Fridolin

    The aim of this study was to evaluate the contribution and removal dynamics of the main fluorophores during dialysis by analyzing the spent dialysate samples to prove the hypothesis whether the fluorescence of spent dialysate can be utilized for monitoring removal of any of the protein bound uremic solute. A high performance liquid chromatography system was used to separate and quantify fluorophoric solutes in the spent dialysate sampled at the start and the end of 99 dialysis sessions, including 57 hemodialysis and 42 hemodiafiltration treatments. Fluorescence was acquired at excitation 280 nm and emission 360 nm. The main fluorophores found in samples were identified as indole derivatives: tryptophan, indoxyl glucuronide, indoxyl sulfate, 5-hydroxy-indoleacetic acid, indoleacetyl glutamine, and indoleacetic acid. The highest contribution (35 ± 11%) was found to arise from indoxyl sulfate. Strong correlation between contribution values at the start and end of dialysis (R2 = 0.90) indicated to the stable contribution during the course of the dialysis. The reduction ratio of indoxyl sulfate was very close to the decrease of the total fluorescence signal of the spent dialysate (49 ± 14% vs 51 ± 13% respectively, P = 0.30, N = 99) and there was strong correlation between these reduction ratio values (R2 = 0.86). On-line fluorescence measurements were carried out to illustrate the technological possibility for real-time dialysis fluorescence monitoring reflecting the removal of the main fluorophores from blood into spent dialysate. In summary, since a predominant part of the fluorescence signal at excitation 280 nm and emission 360 nm in the spent dialysate originates from protein bound derivatives of indoles, metabolites of tryptophan and indole, the fluorescence signal at this wavelength region has high potential to be utilized for monitoring the removal of slowly dialyzed uremic toxin indoxyl sulfate.


  • Open Access

    Paracetamol Interference in Uric Acid Levels in Uremic Patients Revealed by Monitoring Spent Dialysate

    by Risto Tanner, Jürgen Arund, Ivo Fridolin, Merike Luman

    The aim of this study was to assess removal dynamics of paracetamol (PAR), as an extraordinary chromophore in spent dialysate, upon the optical monitoring of dialysis of end-stage renal disease patients with inflammation complications. Seven dialysis sessions of different patients were followed to whom PAR was used as a pain reliever or antipyretic. Spent dialysate was sampled hourly and analyzed using HPLC with MS/MS and UV detection. Quantitative calculations were made on the basis of the peak areas on the chromatograms at 280 nm for uric acid (UA) and 254 nm for PAR and its metabolites (PAR-M). Peaks of UA, PAR, PAR-glucuronide, and PAR-sulphate were identified on the basis of specific mass spectra. Removal of PAR was found to be proportional to that of uric acid if intake of the drug by patient occurred half a day before dialysis. But disturbances of the UV-absorbance curves at 280 nm were observed related to rise of UA concentration in spent dialysate when PAR was taken by patients in the course of dialysis. The mechanism of such relation remains unknown. It was concluded that possible benefits and risks of treatment of uremic patients with paracetamol-containing drugs may need to be reassessed.


  • Open Access

    Do Only Small Uremic Toxins, Chromophores, Contribute to the Online Dialysis Dose Monitoring by UV Absorbance?

    by Jürgen Arund, Risto Tanner, Fredrik Uhlin, Ivo Fridolin

    The aim of this work was to evaluate the contributions of the main chromophores to the total UV absorbance of the spent dialysate and to assess removal dynamics of these solutes during optical on-line dialysis dose monitoring. High performance chromatography was used to separate and quantify UV-absorbing solutes in the spent dialysate sampled at the start and at the end of dialysis sessions. Chromatograms were monitored at 210, 254 and 280 nm routinely and full absorption spectra were registered between 200 and 400 nm. Nearly 95% of UV absorbance originates from solutes with high removal ratio, such as uric acid. The contributions of different solute groups vary at different wavelengths and there are dynamical changes in contributions during the single dialysis session. However, large standard deviation of the average contribution values within a series of sessions indicates remarkable differences between individual treatments. A noteworthy contribution of Paracetamol and its metabolites to the total UV absorbance was determined at all three wavelengths. Contribution of slowly dialyzed uremic solutes, such as indoxyl sulfate, was negligible.


  • Open Access

    Extracorporeal dialysis: techniques and adequacy

    by C. Donadio, A. Kanaki, Adoración Martín-Gómez, Sergio Garcia, Meugenia Palacios-Gómez, Dario Calia, Elisa Colombini, Fabio DI Francesco, Silvia Ghimenti, Massimo Onor, et al.

    Introduction and Aims: There is no consensus on the best method to quantify hemodialysis and the optimal dosage of hemodialysis. Urea is the substance most often measured as a surrogate for the clearance of small molecules. In particular, Kt/V, that is the dialyzer clearance of urea, multiplied by the length of the dialysis session, divided by the volume of distribution of urea, is the most widely accepted indicator of adequacy of hemodialysis. Most commonly Kt/V is estimated, by means of Daugirdas formula, from the values of BUN (postdialysis/predialysis), ultrafiltration volume and postdialysis body weight.